Filing Details
- Accession Number:
- 0001209191-22-016502
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-04 20:03:19
- Reporting Period:
- 2022-03-02
- Accepted Time:
- 2022-03-04 20:03:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1029142 | Dynavax Technologies Corp | DVAX | Pharmaceutical Preparations (2834) | 330728374 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1812025 | Justin Burgess | C/O Dynavax Technologies 2100 Powell Street, Suite 900 Emeryville CA 94608 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-15 | 133 | $10.29 | 3,854 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2022-03-02 | 3,906 | $0.00 | 7,760 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-03 | 3,906 | $10.58 | 3,854 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-03-02 | 8,417 | $0.00 | 12,271 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-03 | 8,417 | $10.58 | 3,854 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-03-02 | 3,167 | $0.00 | 7,021 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-03 | 3,167 | $10.58 | 3,854 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-03-02 | 6,000 | $0.00 | 9,854 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-03 | 6,000 | $10.58 | 3,854 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2022-03-02 | 3,906 | $0.00 | 3,906 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2022-03-02 | 8,417 | $0.00 | 8,417 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2022-03-02 | 3,167 | $0.00 | 3,167 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2022-03-02 | 6,000 | $0.00 | 6,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 16,833 | No | 4 | M | Direct | ||
| 3,166 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- Includes 133 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 15, 2022.
- Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 22, 2019.
- Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 3, 2021.
- Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 12, 2020.
- Each RSU represents a contingent right to receive one share of common stock. The RSUs vest on the second anniversary of February 26, 2020.
Billionaire Hedge Funds
